Showing results (21-30 of 240) with videos related to
Sort By:
Pageof 24
Seminars in Nephrology|October 16, 2012
Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?Alessandro Doria, Monika A Niewczas, Paolo FiorinaCurrent Opinion in Nephrology and Hypertension|April 17, 2003
Diabetes and nephropathyM Luiza Caramori, Michael MauerPediatric Endocrinology Reviews : PER|October 23, 2008
Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patientsJulia M Steinke, Michael Mauer, Diabetologia|September 28, 2015
CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney diseaseRoberto Bassi, Alessia Fornoni, Alessandro Doria, et al.Cell Metabolism|September 3, 2008
The emerging genetic architecture of type 2 diabetesAlessandro Doria, Mary-Elizabeth Patti, C Ronald KahnCurrent Diabetes Reports|May 29, 2013
Temporal profile of diabetic nephropathy pathologic changesCecilia Ponchiardi, Michael Mauer, Behzad NajafianDiabetes Research and Clinical Practice|February 12, 2014
Is diabetic nephropathy reversible?Paola Fioretto, Isabella Barzon, Michael MauerThe Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Genetic variants at the resistin locus and risk of type 2 diabetes in CaucasiansXiaowei Ma, James H Warram, Vincenzo Trischitta, et al.Diabetes|April 10, 2007
Variations in adiponectin receptor genes and susceptibility to type 2 diabetes in women: a tagging-single nucleotide polymorphism haplotype analysisLu Qi, Alessandro Doria, Elena Giorgi, et al.Journal of the American Society of Nephrology : JASN|May 21, 2013
Renal lesions predict progression of diabetic nephropathy in type 1 diabetesM Luiza Caramori, Alicia Parks, Michael MauerPageof 24